Tag: gene therapy

Mehmet Oz, Robert F. Kennedy Jr., Marty Makary, Jay Bhattacharya, Vinay Prasad

Marty Makary and Vinay Prasad embrace a “more fluid concept of evidence” at the FDA

Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "more fluid concept of evidence" now reigns at the FDA—selectively.

/ June 9, 2025
A newborn baby lies on a hospital bed with arms raised, wearing a white knit hat and connected to medical tubes and sensors. The baby is covered with a blanket, and part of a colorful caterpillar design is visible nearby.

Personalized CRISPR Gene Editing Therapy

While the medical world is melting down from the absolute apocalypse that is RFK Jr., it’s good to celebrate that (at least for now) medical progress continues to march on. Recently published in the NEJM is a case report of a breakthrough that we may look back on as a milestone in medicine. Patient-Specific In Vivo Gene Editing to Treat a Rare...

/ May 21, 2025

Deciding Which Risks to Take

No medical treatment is risk-free. Paul Offit's new book covers the history of innovations that went awry and advises how to balance the risks of new medical innovations with the risk of not treating.

/ March 8, 2022
Central Dogma of Molecular Biology

The latest antivax false claim: mRNA vaccines against COVID-19 are not vaccines but “medical devices” or “gene therapy”

There's a new antivaccine talking point in town, and it's just as much disinformation as other antivaccine talking points. It's the claim that mRNA COVID-19 vaccines are not really vaccines but "medical devices," "gene therapy," or "experimental biologics" and that they were falsely classified as vaccines in order to bypass safety testing. Here, we discuss why this claim is utter nonsense based...

/ February 8, 2021
One Million Dollars

Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy?

Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a "pay-to-play" trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn't...

/ December 2, 2019

The Gene: An Intimate History

Six years ago I reviewed Siddhartha Mukherjee’s book The Emperor of All Maladies: A Biography of Cancer. It was hands-down one of the best books I have ever read on a medical topic. Now he’s done it again. His new book is titled The Gene: An Intimate History. Mukherjee is a superb writer. Much of what I said about his first book...

/ July 19, 2016